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Abstract
Background: Microglial activation contributes to the neuropathology associated with chronic alcohol exposure and
withdrawal, including the expression of inflammatory and anti-inflammatory genes. In the current study, we
examined the transcriptome of primary rat microglial cells following incubation with alcohol alone, or alcohol
together with a robust inflammatory stimulus.
Methods: Primary microglia were prepared from mixed rat glial cultures. Cells were incubated with 75 mM ethanol
alone or with proinflammatory cytokines (“TII”: IL1β, IFNγ, and TNFα). Isolated mRNA was used for RNAseq analysis
and qPCR. Effects of alcohol on phagocytosis were determined by uptake of oligomeric amyloid beta.
Results: Alcohol induced nitrite production in control cells and increased nitrite production in cells co-treated with
TII. RNAseq analysis of microglia exposed for 24 h to alcohol identified 312 differentially expressed mRNAs (“Alc-
DEs”), with changes confirmed by qPCR analysis. Gene ontology analysis identified phagosome as one of the
highest-ranking KEGG pathways including transcripts regulating phagocytosis. Alcohol also increased several
complement-related mRNAs that have roles in phagocytosis, including C1qa, b, and c; C3; and C3aR1. RNAseq
analysis identified over 3000 differentially expressed mRNAs in microglia following overnight incubation with TII;
and comparison to the group of Alc-DEs revealed 87 mRNAs modulated by alcohol but not by TII, including C1qa,
b, and c. Consistent with observed changes in phagocytosis-related mRNAs, the uptake of amyloid beta1–42, by
primary microglia, was reduced by alcohol.
Conclusions: Our results define alterations that occur to microglial gene expression following alcohol exposure and
suggest that alcohol effects on phagocytosis could contribute to the development of Alzheimer’s disease.
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Background
Microglial activation occurs in a variety of neurological
conditions and diseases, and increasing number of studies
show that microglial activation contributes to the neuroin-
flammation associated with chronic alcohol exposure and
withdrawal. Studies indicate that innate immune signaling
plays a role in alcohol addiction, and genes implicated in
neuroinflammatory processes accompanying alcoholism
are expressed in microglia [1–3]. Supporting a role for
microglial activation are studies showing that treatment
with minocycline, which selectively reduces microglia acti-
vation, reduces alcohol intake as well as acute actions of
ethanol on sedation and motor impairment [4, 5], and
similarly, treatment of mice with tigecycline, another
tetracycline derivative, reduced alcohol consumption and
clinical features of alcohol consumption in mice [6]. There
are also increasing studies demonstrating that microglia
can be directly activated by alcohol leading to increases in
inflammatory factors including cytokines, chemokines,
transcription factors, and their receptors [1, 2, 7–13]. In
many cases, the effects of alcohol were shown to involve
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activation of the Tlr4 receptor [9, 10, 12, 14–17] which
can directly activate inflammatory transcription factor
NFkB and subsequently increase of inflammatory gene ex-
pression. Alcohol has also increased the expression of
TLRs, in both the liver [18] and the CNS [19, 20]. Other
studies have shown that alcohol also increases expression
and acetylation of HMGB1 which can bind to TLRs and
thereby induce inflammatory gene expression [3, 19].
Despite the above studies that focused on specific
genes or categories of genes, there are few papers which
provide characterization of the microglial transcriptome
following alcohol treatment or consumption. Transcript
profiling has been carried out using RNA from whole
brain [4], amygdala [21], prefrontal cortex [22], and
nucleus accumbens [23] from alcohol-fed mice. While
pathway analysis identified many microglial associated
functions, only a single study has directly examined the
transcriptome of microglia acutely isolated from cortex
of alcohol-fed mice [24]. In that study, over 400 tran-
scripts were identified in the microglial that were not
present in pre-frontal cortical RNA [22], suggesting that
cell type enrichment is necessary to fully characterize
the effects of alcohol on the microglial transcriptome.
While microglial activation and increased pro-
inflammatory cytokine and chemokine expression can
initiate or exacerbate ongoing pathology, microglia also
perform beneficial actions that limit damage in neuro-
logical diseases and conditions. Microglial-mediated pro-
cesses are a key determinant to the accumulation of
amyloid deposits in AD (and its mouse models), playing
roles in amyloid degradation (by metalloproteases in-
cluding neprilysin and insulin degrading enzyme), in re-
moval of amyloid by phagocytosis, and by initiation and
growth of plaques (involving seeding by microglial
inflammasome activation) [25]. Dysregulation of these
processes will alter the balance between amyloid produc-
tion and clearance, with the net result of increased amyl-
oid burden. In Alzheimer’s disease (AD), microglial
phagocytosis of oligomeric and aggregated forms of
amyloid beta (Aβ) is one of the key means by which
amyloid burden is limited [26, 27]. Several studies sug-
gest that alcohol may be a risk factor for AD [28–31],
and there are also reports that alcohol increases amyloid
processing and deposition [32–34]. However, whether al-
cohol influences the ability or efficacy of microglial cells
to internalize Aβ has not been examined, although sev-
eral studies have shown that peripheral macrophages
have reduced phagocytotic activity after alcohol treat-
ment [35, 36].
In the current study, we evaluated the acute effects of
alcohol on inflammatory responses in primary rat micro-
glial cells using RNAseq analysis to define the changes
in gene expression due to alcohol. Our results define al-
terations in microglial mRNA expression following
exposure to alcohol and suggest that alcohol consump-
tion may represent a risk factor for development of
amyloid burden.
Methods
Primary microglial cells
All studies with animals were approved by the UIC Insti-
tutional Animal Care and Use Committee. Primary
mixed glial cells were prepared from the frontal cortices
of grouped male and female post-natal day 2 Sprague
Dawley rats from the same litter [37]. In brief, cerebral
cortices were cleaned from all meninges, digested in
trypsin, and dissociated into single cell suspension by
trituration through syringes. The cells were plated onto
poly-L-lysine-coated flasks and grown in Dulbecco’s
modified Eagle’s media (DMEM) supplemented with
10% heat inactivated fetal bovine serum (FBS) and 1%
antibiotics (P/S; penicillin/streptomycin, Gibco, Ther-
moFisher, Waltham, MA, USA). The next day, cells
were washed with PBS to remove debris, and the
media were changed twice per week. After 7–10 days,
loosely attached microglia were removed from under-
lying astrocytes by shaking flasks at 220 RPM for
30 min at 37 °C. Cells were collected, replated into
dishes in DMEM containing 10% FBS and 1% P/S,
and allowed to adhere overnight. The next day, the
media were changed to serum free DMEM with 1%
N-2 supplement.
Alcohol and cytokine treatment
Microglia were exposed to ethanol in incubator cham-
bers (Modular Incubator Chambers MIC-101, Billups-
Rothenberg Inc. Del Mar, CA) containing either 100 mL
ddH2O alone or 75 mM ethanol. Ethanol was added dir-
ectly to the cell media to bring the final concentration to
75 mM. The chambers were flushed with 5% CO2, 21%
O2, balanced nitrogen mixture from a compressed air
tank at 0.5 psi for 4 min, and then incubated at 37 °C for
24 h. Where indicated, a mixture of pro-inflammatory
cytokines (“TII”, TNFα, 10 ng/ml; IL-1β, 10 ng/ml; and
IFNγ, 10 IU/ml) dissolved in cell culture media was
added to the cells to induce an inflammatory response;
control cells received the equivalent volume of cell
culture media.
Phagocytosis assay
Phagocytosis was assessed in rat primary microglial cells.
For this, the cell culture media was first changed to
serum-free DMEM supplemented with 1% N-2 supple-
ment (Gibco). After 24 h, cells (3.5 × 105 cells/well) were
incubated under control conditions or in medium
containing 75 mM EtOH, TII, or TII with 75 mM EtOH.
After 24 h, the medium was replaced with fresh medium
(control or containing 75 mM EtOH) supplemented
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with 6-carboxyfluorescein (FAM)-labeled Aβ1–42 (0.5 μM;
Anaspec, Fremont, CA, USA). The Aβ peptide was
dissolved in DMSO to obtain a 0.1-mM stock, diluted into
DMEM to a final concentration of 500 nM, then incu-
bated at 37 °C for 1 h to promote aggregation. Cells were
incubated for indicated times, followed by one washing
with PBS to remove Aβ, then harvested using 0.5%
Trypsin (Gibco). Blocking solution containing PBS and
FBS (1:1 ratio) was applied for 10 min on ice. Cells were
collected, resuspended in 400 μl ice cold FACS solution
(PBS supplemented with 2% FCS), and measured by flow
cytometry using the Gallios software (Beckman Coulter’s).
Phagocytosis was analyzed and quantified for total uptake
and for the percentage of cells with internalized Aβ, using
Flowing Software (University of Turku, Finland).
Nitrite production
Inflammatory activation of microglia was assessed indir-
ectly as the production of nitrites in the cell culture
media, an index of the induction of nitric oxide synthase
type 2, measured using Griess reagent. Background
values were obtained using media only and were sub-
tracted from values obtained using cells.
RNA isolation
RNA was isolated using Direct-zol RNA MicroPrep
(Zymo Research, Irvine, CA, USA) according to instruc-
tions. The resulting RNA quality was determined using
the 4200 TapeStation Instrument (Agilent, Santa Clara,
CA), and all samples had RNA integrity numbers (RIN)
above 8.
Library generation
Illumina compatible libraries were prepared from RNA
using QuantSeq 3′ mRNA-seq Library Prep Kit FWD
for Illumina (Lexogen GmbH, Wien, Austria) according
to the manufacturer’s instructions. In brief, library
generation was initiated by oligo-dT priming and first--
strand synthesis. After RNA removal, libraries were sub-
jected to random-primed second-strand synthesis.
Illumina specific linker sequences are added by the pri-
mer, and the resulting double-stranded cDNA purified
with magnetic beads. An additional 12 cycles of PCR
amplification were carried out in order to introduce
barcodes and to generate sufficient amounts of DNA
required for cluster generation. After final purifica-
tion, libraries were measured on TapeStation and
Qubit (ThermoFisher, Waltham, MA) to determine
quantity and size. The resulting libraries were on
average 400-bp size with an average insert size of
270 bp. The method does not require prior poly(A)
enrichment or ribosomal RNA depletion. ERCC (Ex-
ternal RNA Controls Consortium) RNA Spike-In Mix
(Cat# 4456740 Thermo Fisher Scientific, Waltham,
MA) was added to the RNA before library prepar-
ation to allow inter-sample normalization and control
for variabilities.
RNA sequencing and analysis
Barcoded libraries were pooled and sequenced on Illu-
mina NextSeq system (Illumina, San Diego, CA, USA)
producing about 500 M reads of non-paired 75-nt
sequence. Up to 32 barcoded samples were pooled to-
gether producing on average 12 M reads per sample.
RNAseq analysis was carried out using the BaseSpace
platform from Illumina. The RNAseq-generated FASTQ
files were aligned to the USCSrn5 Rattus norvegicus ref-
erence genome with STAR aligner [38] with allowed
mismatches set to 14. Differentially expressed (DE)
mRNAs were determined using the DeSeq2 package
based on the negative binomial distribution and a
false discovery rate of 0.1% [39]. In brief, paired
RNAseq data for each transcript are compared using
Wald testing which is a more powerful method than
others to detect significant differences in low expres-
sion transcripts [40]; those with Wald p values < 0.05
are ordered, and an adjusted p value is then deter-
mined using Benjamini-Hochberg approach to
minimize false discovery to 0.1% or less. This method
does not take into consideration the magnitude of the
difference in expression. Functional and pathway ana-
lysis were performed using DAVID [41] and GO Con-
sortium [42, 43] platforms.
Quantitative real-time PCR
Whole cell RNA (1 μg) was converted to cDNA using
the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems cat #4368814, ThermoFisher,
Waltham, MA, USA). The cDNA was amplified using
FastStart Universal SYBR Green Master mix (Applied
Biosystems, cat #04913914001, Foster City, CA, USA)
in a Corbett RotoGene real-time PCR machine
(Qiagen, Germantown, MD). The relative levels of mRNA
were calculated from threshold take-off cycle number and
normalized to values measured for β-actin in the same
samples.
Data analysis
Data are presented as mean ± SEM of at least three inde-
pendent experiments. qPCR data were compared using
Student’s t tests. Nitrite data were compared using one-
way parametric ANOVA and Tukey’s post hoc compari-
sons. Phagocytosis data were analyzed for Gaussian
distribution; all data passed normality test so compari-
sons were performed with one-way ANOVA and Tukey’s
post hoc comparisons.
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Results
Alcohol increases microglial inflammatory activation
Enriched (> 95%) primary microglia were prepared by
the shake-off method from postnatal day 2 rat cortical
mixed glial cultures, then incubated with 75 mM
ethanol, with or without TII to induce inflammatory ac-
tivation as assessed by measurement of nitrite levels in
the culture media. Under these conditions, ethanol alone
increased nitrite levels about twofold above control
values (Fig. 1). Incubation with TII increased nitrite
production about threefold over control, and that was
further increased (to about fourfold control values) when
ethanol was present.
Alcohol-dependent changes in microglial mRNA
RNAseq analysis was used to identify mRNAs regulated
by exposure to alcohol. Of 17,327 genes in the rat refer-
ence genome, 15,062 mRNAs were identified having over
0.1 FPKM (Additional file 1: Table S6); of those, 312 were
differentially expressed (DE) following ethanol treatment
(“Alc-DEs”; Additional file 1: Table S1). The majority of
Alc-DEs (230) were increased, while 82 were decreased by
ethanol. Of those, 274 were changed by at least 20% and
19 changed by at least 50%. Gda (guanine deaminase) was
the mRNA most decreased (to about 50% of control
values), and Robo1 (roundabout guidance receptor 1) and
Plxdc2 (plexin domain containing 2) were the most in-
creased (to 170% of control values) by alcohol. Quantita-
tive reverse-transcription PCR (qPCR) of the mRNAs
showing the largest changes, as well as of several other
mRNAs selected for having important functional conse-
quences, validated RNAseq results (Fig. 2).
To compare microglial responses to alcohol to those
elicited by an inflammatory stimulus, we carried out
RNAseq on RNA from TII-treated microglia. In contrast
to alcohol, there was a dramatic alteration in mRNA ex-
pression due to this robust stimulus. Using the same cri-
teria (P values adjusted for an FDR of < 0.1%), we
identified 3082 mRNAs modified by TII (“TII-DEs”;
Additional file 1: Table S2). Of those, 1266 were changed
by over 50%; 43 mRNAs increased over 10-fold; and 21
decreased by at least 10-fold. To determine how alcohol
influences microglial gene expression in the context of
inflammation, we carried out RNAseq of mRNA from
cells treated with TII together with ethanol. A total of
3552 mRNAs were identified (“AlcTII-DEs”, Additional
file 1: Table S3), slightly more than that due to TII alone.
Of those, 1432 were changed by over 50%, 53 mRNAs
were increased over 10-fold, and 25 were decreased by
at least 10-fold.
Comparison (Fig. 3 and Additional file 1: Table S4) of
Alc-DEs (regions 1, 2, 4, and 5) to TII-DEs (regions 2, 3,
5, and 6) shows that 225 of the 312 Alc-DEs are present
in both groups (regions 2 and 5). The remaining 87
Alc-DEs (regions 1 and 4) are not induced by a robust
inflammatory stimulus; therefore, these represent a non-
canonical type of microglial activation; we refer to this
group as Alc*-DEs. Further comparison to the AlcTII-
DE group shows that 21 DEs (“AlcOnly-DEs”, region 1)
are found only in the Alc-DE group. Comparison of
AlcTII-DEs to TII-DEs shows considerable overlap
(2601 DEs, regions 5 and 6) between these two groups;
as well as an additional 951 (“AlcInf-DEs”, regions 4 and
7) that are not detected in the TII group. Of those 951
AlcInf-DEs, 885 (“Alc*TII-DEs”, region 7) are increased
by alcohol only in the context of inflammation but not
by alcohol or by TII alone.
Gene Ontology analysis (DAVID) identified five KEGG
pathways enriched in the 312 Alc-DE group (Additional
file 1: Table S5A), with one of the highest categories be-
ing phagosome containing 15 transcripts (Atp6ap1, C3,
Calr, Coro1a, Ctss, Cyba, Fcgr1a, Itgb5, Ncf1, RT1-A1,
RT1-CE14, RT1-N3, RT1-S3, Tuba1b, and Tlr2). In
addition, a Gene Ontology Consortium analysis [42, 43]
identified a ninefold enrichment in transcripts involved
in regulation of phagocytosis including Psap, Pycard,
CD300lf, Slc11a1, Mfge8, and Sirpa. DAVID analysis of
the 21 AlcOnly-DEs did not identify any enriched GO
terms or KEGG pathways likely due to the small group
size. However, four members (C1qb, Ifih1, Ly86, and
Tmem30a) play roles in the innate immune system and
Tlr4 signaling, and three members (Laptm5, Map1Lc3a,
and Uba7) are involved in protein degradation. In the
group of 87 alcohol-specific Alc*-DEs, only endoplasmic
reticulum (ER) was identified as an enriched cytosolic
component. However, this group includes all 3 isoforms
Fig. 1 Alcohol increases microglial inflammatory activation. Primary
rat microglia were incubated overnight with nothing (control), with
TII to induce an inflammatory response, with 75 mM ethanol (Alc),
or with TII and ethanol (Alc and TII). The next day, nitrite production
was measured using Griess reagent. The data is the mean ± sem of
n = 6–15 replicates done in 3 independent studies. *P < 0.05; ***P <
0.0001; one-way ANOVA, Tukey’s post hoc analysis
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of complement protein C1q, as well as 7 other mRNAs
(Oas1b, Rtp4, Ifih1, Pou2f2, Kdelr1, Coro1a, and Ddx58)
involved in immune effector responses. There are four
KEGG pathways identified in the group of 885 Alc*TII-
DEs (Additional file 1: Table S5B), three of which involve
RNA handling (ribosome, spliceosome, and transport)
and one involves Salmonella infection. Interestingly,
while levels of 14 of the 18 mRNAs encoding nuclear
ribosomal subunits were decreased, the levels of 7 of the
8 mRNAs encoding mitochondrial ribosomal subunits
were increased.
Alcohol reduces microglial phagocytosis
Since phagocytosis was one of the highest KEGG path-
ways identified in the Alc-DE group, we tested if alcohol
influenced microglial phagocytosis. In primary rat
microglial cells, overnight exposure to alcohol reduced
phagocytosis of fluorescently labeled oligomeric Aβ1–42
(Fig. 4a, b). In these cells, incubation with TII cytokines
also reduced Aβ phagocytosis compared to control cells,
but that reduction was not affected by the presence of
alcohol (Fig. 4c, d). Quantitation of the average amount
of Aβ internalized over 45 min shows a significant 16%
reduction due to alcohol and a 37% reduction due to TII
(Fig. 4e).
Discussion
Several studies have examined the effects of alcohol con-
sumption on neuroinflammatory gene expression. Tran-
script profiling has been carried out using RNA from the
whole brain of mice fed alcohol 4 h per day for 4 days
[4]; from amygdala (AMY) after 30 days drinking using a
2-bottle choice [21]; from prefrontal cortex (PFC) after
chronic (30 day), chronic intermittent (every other day
for 29 days) or drinking in the dark (DID, 4 h in the dark
for 36 days) [22]; and from PFC, Nucleus Accumbens
(NAC), and AMY after 4 weekly cycles of chronic inter-
mittent drinking [23]. In these studies, pathway analysis
identified enrichment for many microglial mRNAs and
networks, consistent with a role for microglia activation
by alcohol. In microglia acutely isolated from prefrontal
cortex of mice after alcohol consumption for 60 days in
an every-other day drinking paradigm [24], 1010
Alc-DEs were identified in the microglial samples, com-
pared to 2461 in total homogenates. Of the 1010 DEs,
846 were unique to microglia and not detected in the
total homogenates. Similar to our findings, the largest
Fig. 2 Validation of RNAseq results. Reverse transcriptase quantitative PCR (qPCR) was used to measure mRNA levels of the indicated Alc-DEs.
qPCR was carried out in samples from microglia incubated for 24 h with nothing (control, n = 3) or 75 mM ethanol (n = 3), and results normalized
to values measured for β-actin in the same samples. The y-axis shows the ratio of the average mRNA level measured in the ethanol versus the
control samples (filled bars) and is plotted next to the fold-difference calculated from RNAseq data (open bars). For qPCR results, *P < 0.05; #P <
0.10 control vs alcohol. For the RNAseq data, all DEs were found significantly different using Deseq2
Fig. 3 Overlap of identified DEs. A Venn diagram illustrating overlap
of Alc-DEs (n = 312; orange, regions 1, 2, 4, and 5), TII-DEs (n = 3082;
green, regions 2, 3, 5, and 6) and AlcTII-DEs (n = 3552; blue, regions 4,
5, 6, and 7). The full list of the DEs in each group is provided
in Additional file 1: Tables S1-S4
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differences were less than twofold for the DEs. Overall,
comparison of the 846 alcohol-induced microglial spe-
cific changes to the 312 Alc-DEs identified in the
current study showed only 28 overlapping mRNAs.
Whether this large difference reflects the long duration
of the in vivo paradigm compared to a relatively brief
24 h period of in vitro exposure or to differences be-
tween acutely isolated microglia to primary microglial
prepared from mixed glial cultures is not known.
In our study, the average change in the 313 Alc-DEs
was 16%, ranging from a 50% decrease to a 72% increase.
While modest, these changes are consistent with those
reported for microglial transcripts in other studies. In
enriched microglia isolated from CTX of alcohol-fed rats
[24], the majority of DEs had expression changes be-
tween log2 of 0.125 (9%) and 0.375 (30%); changes for
the total cortical homogenates were somewhat greater,
ranging from log2 of 0.10 (7%) to about 0.5 (50%). In a
study of microRNAs, the analysis for DEs used cutoff
thresholds of 5% [23], and in a study of synaptosomal
transcripts [21], the majority of transcripts showed fold
changes on the order of 20% or less. These changes are
consistent with reports that modest differences in
alcohol-induced gene expression are common for CNS
[44]. These observations suggest that modest changes in
a set of functionally related mRNAs (and associated pro-
teins) can exert as significant an effect as does a robust
change in expression of a single transcript.
In addition to identification of genes altered by alcohol
use, studies have been carried out in rodent [45–48] and
human samples to identify gene expression patterns that
correlate with alcohol use or preference [49–52]. A com-
parative network analysis of RNAseq data from rats bred
for either high (SHR) or low (BN-LX) alcohol prefer-
ence, and by including correlation to phenotypic data
from a recombinant inbred population, allowed identifi-
cation of candidate genes associated with alcohol con-
sumption [47], many of which were known to be
expressed in microglia (or astrocytes). Analysis of RNA
from brain regions of alcoholic compared to non-
alcoholic patients have identified patterns of gene ex-
pression that discriminate between groups [51, 52]. In
the nucleus accumbens of patients with alcohol depend-
ency, over 4500 transcripts were identified as being dif-
ferentially expressed, which could be clustered into 24
mRNA co-expression networks of which 6 were signifi-
cantly correlated with dependency [52] and 4 were
enriched for glial transcripts. However, in these cases, it
is not known if expression changes were direct conse-
quences of alcohol, or secondary to alcohol-induced
damage.
In our studies, pathway analysis using DAVID [41] and
GO Consortium [42, 43] platforms identified 5 KEGG
pathways enriched in the 312 Alc-DE group, with phago-
some being one of highest including transcripts for
Atp6ap1, C3, Calr, Cd300lf, Coro1a, Ctss, Cyba, Fcgr1a,
Itgb5, Mfge8, Ncf1, Psap, Pycard, RT1-A1, RT1-CE14,
RT1-N3, RT1-S3, Sirpa, Slc11a1, and Tlr2. Many of
these genes regulate the processes of phagocytosis and
degradation (Table 1). In addition, we found that alcohol
a b
c d e
Fig. 4 Alcohol reduces amyloid beta phagocytosis in rat microglia. Primary rat microglia were incubated overnight with a nothing (control),
b 75 mM ethanol, c TII, or d 75 mM ethanol and TII. The next day, the cells were assayed by flow cytometry for phagocytosis of FAM-labeled
oligomeric Aβ1–42. e Average internalized FAM fluorescence per cell. Data is from 3 different batches of microglial cells totaling 9197 (controls),
8976 (alcohol), 24,588 (TII), and 28,773 (Alc * TII) events. *P < 0.005 versus control cells, one-way ANOVA, Tukey’s post hoc analysis
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increased levels of several complement transcripts, in-
cluding C1qa,b, and c; C3; and C3aR1, and moreover
that the C1q variants were not increased by TII alone.
This is consistent with studies showing that alcohol in-
creases complement proteins, including C1q, C3a, C5a,
C3aR, and C5aR, in liver [65, 66] and adipose tissue
[67]. Since microglial complement activation can cause
neuronal damage [68], these findings suggest that C1q
induction in the brain could contribute to alcohol-
induced neuropathology. While this may be mediated
through activation of the complement pathways, obser-
vations that several complement proteins, including C1q
and C3b promote phagocytosis [69, 70] and that CR3
regulates amyloid clearance [71–74], suggests that
alcohol-induced changes in complement expression may
also regulate microglial phagocytosis of amyloid.
Our results demonstrate that microglial phagocytosis
of Aβ1–42 is significantly suppressed following 1-day ex-
posure to 75 mM ethanol. This dose of ethanol is in the
high range and is attained in human following binge
drinking or in heavy drinkers. Similar doses have previ-
ously been used to study phagocytosis in vitro [33, 36].
Suppressive effects of alcohol on phagocytosis have
previously been reported in studies examining macro-
phages (see [35] for review). Alcohol reduces uptake of
Pseudomonas aeruginosa [36], and of Candida albicans
[75], and inhibition can be seen as soon as 1 h after
treatment with ethanol [76]. In contrast to macrophages,
there are limited studies of the effects of alcohol expos-
ure on microglial phagocytosis. In neonatal mice [77],
acute binge-like alcohol exposure induced microglial ac-
tivation and phagocytosis of damaged neurons, suggest-
ing that acute ethanol exposure could be protective
during early development. It was also shown using a
similar acute exposure model, that although activated
microglia were observed near to dead cells in the
cortex, that apoptotic bodies accumulated, interpreted
that the rate of cell death exceeded microglial clear-
ance capacity [78]. In embryonic stem cell-derived
microglia [79], 48-h exposure to 100 mM ethanol de-
creased phagocytosis of fluorescently labeled E. coli
particles by 15% compared to control cells. These
findings are consistent with the ability of alcohol to
inhibit microglia in vivo.
In our studies, alcohol exposure reduced phagocytosis
of Aβ with no effect on uptake of polystyrene beads (un-
published findings, DLF). Aβ phagocytosis is regulated
by various proteins several of which were identified as
being induced by alcohol treatment. In primary micro-
glia, activation of SIRPb1 (signal regulatory protein beta-
1) increased phagocytosis of fibrillary Aβ, as well as of
microsphere beads [80]. In contrast, inhibition of CLIC1
(chloride intracellular ion channel) increased Aβ phago-
cytosis, possibly via suppression of pro-inflammatory
cytokine or iNOS induction [81], while inhibition had no
effect on bead uptake. The basis for this difference is not
known, but may be related to the ability of Aβ but not
Table 1 Phagosome-related mRNA enriched in alcohol-treated
microglia
Symbol Name and function
Coro1a Coronin1a
Cell membrane associated protein that interacts
with actin filaments to facilitate cell motility,
endocytosis, and phagocytosis. Loss of Coro1a
expression or ability to bind to F-actin impairs
these processes [53].
ATP6ap1 ATPase H+ transporting accessory protein 1
Component of the H+ transporting vacuolar
ATPase present in phagosomes [54]
Fcgr1a Fc fragment of IgG receptor Ia
Complexes with leukotriene B4 receptor in
lipid rafts, enhances macrophage anti-
microblial actions [55]
RT1 Proteins of the MHC class I family, involved in
antigen presentation.
Ctss Cathepsin S
Peptidase present in phagolysosomes where it
degrades various target proteins [56]
Cyba Cytochrome b-245 alpha chain
Ncf1 Neutrophil cytosolic factor 1
Components of the NADPH Oxidase complex,
present in phagolysomes.
Slc11a1 Solute carrier family 11 member a1, also referred
to as Nramp1
Transmembrane phagosomal divalent cation
transporter [57]
Mfge8 Ligand milk fat globule EGF factor-8
Ligand for Itgb5 (integrain subunit beta 5) required for
activation of several pathways, including MerTK activation
and F-actin recruitment, involved in clearance [58]
Psap Prosaponin
Precursor of saposins A, B, C, and D, which have
roles in lysomal degradation pathways [59]
Sirpa Signal regulatory protein alpha
Macrophage receptor for CD47 which is a broad
inhibitor of phagocytosis [60, 61]
Calr Calreticulin
When present on the cell surface acts as a signal
to activate macrophage phagocytosis [62]
CD300lf Member of the CD300 receptor family
Roles in activating macrophage engulfment by
phosphatidylserine signaling [63]
Pycard PYD And CARD Domain Containing, also referred
to as ASC (Apoptosis-Associated Speck-Like)
Component of the NLRP3 inflammasome, recently
shown to play a role in amyloid deposition. [64]
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polystyrene beads to induce microglia cytokine produc-
tion, which in turn regulates phagocytotic activities.
Alcohol consumption is generally considered a risk
factor for dementia, although there are some inconsist-
encies which may depend upon age, gender, amounts
consumed, and numerous other genetic and environ-
mental factors. Indications that alcohol can worsen or
accelerate dementia may contribute to the risk or
progression AD; however, those studies do not address if
alcohol specifically modifies AD pathogenesis. Analysis
of 125 brain autopsy samples showed that, as expected,
higher Aβ immunoreactivity (Aβ-IR) was associated with
increased age and ApoE4 allele [82]. However, Aβ-IR
was significantly inversely associated with beer drinking
with an odds ratio close to 0.35, although the signifi-
cance was reduced when stratified for age and ApoE4
[82]. Epidemiological studies report a reduction in AD
prevalence due to low alcohol ingestion, and protective ef-
fects in those having moderate consumption [30]. Simi-
larly, a prospective study of over 3000 subjects over
3 years found that light to moderate alcohol consumption
reduced the risk of overall dementia by about 30% [83]. In
contrast, a recent review of the literature to determine if
alcohol consumption is a risk factor for AD concluded
that alcohol use causes cognitive impairment by contribut-
ing to the neurodegenerative processes [84]. A systematic
review concluded that there is as yet no consensus on this
issue and that despite several studies, alcohol should not
be considered methods to reduce AD risk [85].
In contrast, evidence that alcohol can increase amyloid
levels comes from several studies. In vitro, low ethanol
exposure, equivalent to moderate alcohol usage,
decreased Aβ binding to neurons and thereby reduced
neurotoxic actions of Aβ [86] which may account for
protective actions at low to moderate doses. Exacerba-
tion of AD pathogenesis by alcohol has been reported
using both in vitro and in vivo studies. In human, SK-N-
MC neuroblastoma cells ethanol upregulated BACE1
expression and Aβ production, as well as increased react-
ive oxygen species (ROS) production, cyclooxygenase-2
(COX-2) expression and PGE2 production [32]. Ethanol
exposure of mice for 4 weeks increased APP levels and
BACE1 expression, promoted Aβ production, increased
plaque deposition, and worsened cognitive deficits [33].
Adult rats fed alcohol for 5 weeks had increased levels of
APP and BACE1 in several brain regions and increased
presenilin-1 and nicastrin in the hippocampus [34]. Long-
term alcohol consumption significantly impaired spatial
memory in adult rats, which may be a contributing factor
to development of AD [87]. These findings show that
alcohol increases amyloidogenic processing, a mech-
anism which could contribute to plaque burden.
However, it is not known if increases in plaque num-
bers were dependent on reduced microglial activities
(e.g., phagocytosis) which otherwise could compensate
for increased Aβ production.
The current findings have several limitations, a pri-
mary one being that these studies were done using
enriched cultures of primary rat microglia, which differ
from acutely isolated brain microglia in terms of gene
expression and function. It is therefore important that
analogous studies be carried out to test the effects of al-
cohol consumption on the microglial transcriptome, and
on amyloid phagocytosis, in a transgenic mouse model
of amyloid deposition. Second, we only evaluated effects
of a single acute exposure to ethanol, which likely will
differ from effects following chronic exposure. Since
alcohol consumption in humans can involve periods of
consumption followed by periods of withdrawal, it is
important to determine how withdrawal influences
microglial gene expression and phagocytosis.
Conclusion
These results define the changes that occur to microglial
cells following exposure to physiologically relevant
amounts of ethanol. While changes in inflammatory
mRNAs were expected, observations that alcohol
induces changes in mRNAs involved in phagocytosis in-
cluding members of the complement system is a novel
finding suggesting that alcohol consumption can lead to
dysregulation of clearance processes in the CNS. In vitro
results showing reduced uptake of Aβ, together with the
finding that alcohol increase Pycard (ASC) expression
which can play a role in amyloid plaque formation, have
important implications for AD patients as well as those
at risk to develop disease.
Additional file
Additional file 1: Table S1. Differentially expressed mRNAs due to
alcohol treatment “Alc-DEs”. Shading indicates mRNA levels were
confirmed by qPCR. Table S2 Differentially expressed mRNAs due to TII
treatment “TII-DEs”. Table S3 Differentially expressed mRNAs due to
alcohol and TII treatment “AlcTII-DEs”. Table S4 Treatment-group overlap
of differentially expressed mRNAs. Grey, involved in immune effector
responses; Blue, mitochondrial ribosomal subunit; Orange, nuclear
ribosomal subunit. Table S5 KEGG pathways identified in treatment
groups. Table S6 FPKM (fragments per kilobase of transcript per million
fragments mapped). (ZIP 3000 kb)
Abbreviations
AD: Alzheimer’s disease; Alc*-DEs: DEs induced by alcohol or alcohol plus TII,
but not by TII alone; Alc-DEs: DEs induced by alcohol treatment; AlcInf-DEs: DEs
only induced by alcohol plus TII treatment; AlcOnly-DEs: DEs only induced by
alcohol alone; AlcTII-DEs: DEs induced by alcohol plus TII treatment;
AMY: Amygdala; APP: Amyloid precursor protein; DE: Differentially expressed;
DID: Drinking in the dark; DMEM: Dulbecco’s modified Eagle’s media;
ERCC: External RNA Controls Consortium; FACS: Flow activated cell sorting;
FAM: 6-Carboxyfluorescein; GO: Gene ontology; IFNγ: Interferon gamma;
IL1β: Interleukin 1-beta; NAC: Nucleus accumbens; PFC: Prefrontal cortex;
qPCR: Quantitative reverse-transcription PCR; RNAseq: RNA sequencing;
ROS: Reactive oxygen species; TII: Mixture of IL1β, IFNγ, and TNFα; TII-DEs: DEs
induced by TII treatment; TNFα : Tumor necrosis factor alpha
Kalinin et al. Journal of Neuroinflammation  (2018) 15:141 Page 8 of 11
Funding
This work was supported in part by grant NIAAA P50AA-022538 (SCP) and a
Research Career Scientist award from the Department of Veterans Affairs
(DLF and SCP).
Availability of data and materials
All data generated or analyzed during this study are included in this
published article and its additional files.
Authors’ contributions
SK performed the RNAseq studies and qPCRs. MG-P and HS performed the
phagocytosis assays. LL performed the nitrite assays. HK performed the qPCR
verifications. MTH and JLMM designed the phagocytosis assays. SCP conceived
the design of alcohol treatments and RNAseq experiments. DLF conceived the
design of experiments, collected and analyzed the data, and wrote the
manuscript. All authors read and approved the final manuscript.
Ethics approval
All experiments were conducted with approval of the University of Illinois
Institutional Animal Care and Use Committee (protocol number 15-129).
Competing interests
The authors declare that they have no competing interests
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL
60612, USA. 2Department of Pharmacology, University Complutense, Centro
de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid
28040, Spain. 3Department of Neurodegenerative Disease and Geriatric
Psychiatry, University of Bonn, 53127 Bonn, Germany. 4Institute of
Pharmacology, Catholic University Medical School, 00168 Rome, Italy. 5Center
for Alcohol Research in Epigenetics, Department of Psychiatry, University of
Illinois at Chicago, Chicago, IL 60612, USA. 6Department of Veterans Affairs,
Jesse Brown VA Medical Center, Chicago, IL 60612, USA.
Received: 25 April 2018 Accepted: 29 April 2018
References
1. Robinson G, Most D, Ferguson LB, Mayfield J, Harris RA, Blednov YA.
Neuroimmune pathways in alcohol consumption: evidence from behavioral
and genetic studies in rodents and humans. Int Rev Neurobiol. 2014;118:13–39.
2. Warden A, Erickson E, Robinson G, Harris RA, Mayfield RD. The
neuroimmune transcriptome and alcohol dependence: potential for
targeted therapies. Pharmacogenomics. 2016;17:2081–96.
3. Crews FT, Lawrimore CJ, Walter TJ, Coleman LG Jr. The role of
neuroimmune signaling in alcoholism. Neuropharmacology. 2017;122:56–73.
4. Agrawal RG, Hewetson A, George CM, Syapin PJ, Bergeson SE. Minocycline
reduces ethanol drinking. Brain Behav Immun. 2011;25(Suppl 1):S165–9.
5. Wu Y, Lousberg EL, Moldenhauer LM, Hayball JD, Robertson SA, Coller JK,
Watkins LR, Somogyi AA, Hutchinson MR. Attenuation of microglial and IL-1
signaling protects mice from acute alcohol-induced sedation and/or motor
impairment. Brain Behav Immun. 2011;25(Suppl 1):S155–64.
6. Martinez JM, Groot JA, Curtis DC, Allison CL, Marquardt PC, Holmes AN,
Edwards DS, Trotter DR, Syapin PJ, Finn DA, Bergeson SE. Effective reduction
of acute ethanol withdrawal by the tetracycline derivative, tigecycline, in
female and male DBA/2J mice. Alcohol Clin Exp Res. 2016;40:2499–505.
7. Blanco AM, Pascual M, Valles SL, Guerri C. Ethanol-induced iNOS and COX-2
expression in cultured astrocytes via NF-kappa B. Neuroreport. 2004;15:681–5.
8. Alfonso-Loeches S, Urena-Peralta J, Morillo-Bargues MJ, Gomez-Pinedo U,
Guerri C. Ethanol-induced TLR4/NLRP3 neuroinflammatory response in
microglial cells promotes leukocyte infiltration across the BBB. Neurochem
Res. 2016;41:193–209.
9. Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C.
Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and
brain damage. J Neurosci. 2010;30:8285–95.
10. Fernandez-Lizarbe S, Pascual M, Guerri C. Critical role of TLR4 response in the
activation of microglia induced by ethanol. J Immunol. 2009;183:4733–44.
11. Fernandez-Lizarbe S, Pascual M, Gascon MS, Blanco A, Guerri C. Lipid rafts
regulate ethanol-induced activation of TLR4 signaling in murine
macrophages. Mol Immunol. 2008;45:2007–16.
12. Blanco AM, Guerri C. Ethanol intake enhances inflammatory mediators in brain:
role of glial cells and TLR4/IL-1RI receptors. Front Biosci. 2007;12:2616–30.
13. Valles SL, Blanco AM, Pascual M, Guerri C. Chronic ethanol treatment
enhances inflammatory mediators and cell death in the brain and in
astrocytes. Brain Pathol. 2004;14:365–71.
14. Fernandez-Lizarbe S, Montesinos J, Guerri C. Ethanol induces TLR4/TLR2
association, triggering an inflammatory response in microglial cells. J
Neurochem. 2013;126:261–73.
15. Pandey SC. TLR4-MyD88 signalling: a molecular target for alcohol actions. Br
J Pharmacol. 2012;165:1316–8.
16. Blanco AM, Valles SL, Pascual M, Guerri C. Involvement of TLR4/type I IL-1
receptor signaling in the induction of inflammatory mediators and cell death
induced by ethanol in cultured astrocytes. J Immunol. 2005;175:6893–9.
17. Montesinos J, Alfonso-Loeches S, Guerri C. Impact of the innate immune
response in the actions of ethanol on the central nervous system. Alcohol
Clin Exp Res. 2016;40:2260–70.
18. Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, Franchimont
D, Louis H, Deviere J, Le Moine O. Differential liver sensitization to toll-like receptor
pathways in mice with alcoholic fatty liver. Hepatology. 2006;43:989–1000.
19. Lippai D, Bala S, Petrasek J, Csak T, Levin I, Kurt-Jones EA, Szabo G. Alcohol-
induced IL-1beta in the brain is mediated by NLRP3/ASC inflammasome
activation that amplifies neuroinflammation. J Leukoc Biol. 2013;94:171–82.
20. Crews FT, Qin L, Sheedy D, Vetreno RP, Zou J. High mobility group box 1/
toll-like receptor danger signaling increases brain neuroimmune activation
in alcohol dependence. Biol Psychiatry. 2013;73:602–12.
21. Most D, Leiter C, Blednov YA, Harris RA, Mayfield RD. Synaptic microRNAs
coordinately regulate synaptic mRNAs: perturbation by chronic alcohol
consumption. Neuropsychopharmacology. 2016;41:538–48.
22. Osterndorff-Kahanek E, Ponomarev I, Blednov YA, Harris RA. Gene expression in
brain and liver produced by three different regimens of alcohol consumption
in mice: comparison with immune activation. PLoS One. 2013;8:e59870.
23. Osterndorff-Kahanek EA, Tiwari GR, Lopez MF, Becker HC, Harris RA, Mayfield
RD. Long-term ethanol exposure: temporal pattern of microRNA expression
and associated mRNA gene networks in mouse brain. PLoS One. 2018;13:
e0190841.
24. McCarthy GM, Farris SP, Blednov YA, Harris RA, Mayfield RD. Microglial-
specific transcriptome changes following chronic alcohol consumption.
Neuropharmacology. 2018;128:416–24.
25. Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker
A, Schwartz S, Santarelli F, Kummer MP, et al. Microglia-derived ASC specks cross-
seed amyloid-beta in Alzheimer's disease. Nature. 2017;552:355–61.
26. Ries M, Sastre M. Mechanisms of Abeta clearance and degradation by glial
cells. Front Aging Neurosci. 2016;8:160.
27. Zuroff L, Daley D, Black KL, Koronyo-Hamaoui M. Clearance of cerebral
Abeta in Alzheimer’s disease: reassessing the role of microglia and
monocytes. Cell Mol Life Sci. 2017;74:2167–201.
28. Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors
associated with the onset and progression of Alzheimer’s disease: a
systematic review of the evidence. Neurotoxicology. 2017;61:143–87.
29. Heymann D, Stern Y, Cosentino S, Tatarina-Nulman O, Dorrejo JN, Gu Y. The
association between alcohol use and the progression of Alzheimer’s
disease. Curr Alzheimer Res. 2016;13:1356–62.
30. Huang WJ, Zhang X, Chen WW. Association between alcohol and
Alzheimer’s disease. Exp Ther Med. 2016;12:1247–50.
31. Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and
risk of dementia. J Am Geriatr Soc. 2004;52:540–6.
32. Gabr AA, Lee HJ, Onphachanh X, Jung YH, Kim JS, Chae CW, Han HJ.
Ethanol-induced PGE2 up-regulates Abeta production through PKA/CREB
signaling pathway. Biochim Biophys Acta. 1863;2017:2942–53.
33. Huang D, Yu M, Yang S, Lou D, Zhou W, Zheng L, Wang Z, Cai F, Zhou W,
Li T, Song W. Ethanol alters APP processing and aggravates Alzheimer-
associated phenotypes. Mol Neurobiol. 2017. https://doi.org/10.1007/
s12035-017-0703-3.
34. Kim SR, Jeong HY, Yang S, Choi SP, Seo MY, Yun YK, Choi Y, Baik SH, Park JS,
Gwon AR, et al. Effects of chronic alcohol consumption on expression levels
of APP and Abeta-producing enzymes. BMB Rep. 2011;44:135–9.
Kalinin et al. Journal of Neuroinflammation  (2018) 15:141 Page 9 of 11
35. Karavitis J, Kovacs EJ. Macrophage phagocytosis: effects of environmental
pollutants, alcohol, cigarette smoke, and other external factors. J Leukoc
Biol. 2011;90:1065–78.
36. Karavitis J, Murdoch EL, Deburghgraeve C, Ramirez L, Kovacs EJ. Ethanol
suppresses phagosomal adhesion maturation, Rac activation, and
subsequent actin polymerization during FcgammaR-mediated phagocytosis.
Cell Immunol. 2012;274:61–71.
37. Madrigal JL, Feinstein DL, Dello Russo C. Norepinephrine protects cortical
neurons against microglial-induced cell death. J Neurosci Res. 2005;81:390–6.
38. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P,
Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner.
Bioinformatics. 2013;29:15–21.
39. Love MI, Huber W, Anders S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
40. Chen Z, Liu J, Ng HK, Nadarajah S, Kaufman HL, Yang JY, Deng Y. Statistical
methods on detecting differentially expressed genes for RNA-seq data. BMC
Syst Biol. 2011;5(Suppl 3):S1.
41. Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens
R, Baseler MW, Lane HC, Lempicki RA. The DAVID Gene Functional
Classification Tool: a novel biological module-centric algorithm to
functionally analyze large gene lists. Genome Biol. 2007;8:R183.
42. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP,
Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification
of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25–9.
43. The Gene Ontology Consortium. Expansion of the Gene Ontology
knowledgebase and resources. Nucleic Acids Res. 2017;45:D331–d338.
44. Lovinger DM, Crabbe JC. Laboratory models of alcoholism: treatment target
identification and insight into mechanisms. Nat Neurosci. 2005;8:1471–80.
45. Kimpel MW, Strother WN, McClintick JN, Carr LG, Liang T, Edenberg HJ,
McBride WJ. Functional gene expression differences between inbred
alcohol-preferring and -non-preferring rats in five brain regions. Alcohol.
2007;41:95–132.
46. Tabakoff B, Saba L, Kechris K, Hu W, Bhave SV, Finn DA, Grahame NJ,
Hoffman PL. The genomic determinants of alcohol preference in mice.
Mamm Genome. 2008;19:352–65.
47. Saba LM, Flink SC, Vanderlinden LA, Israel Y, Tampier L, Colombo G,
Kiianmaa K, Bell RL, Printz MP, Flodman P, et al. The sequenced rat brain
transcriptome—its use in identifying networks predisposing alcohol
consumption. FEBS J. 2015;282:3556–78.
48. Carr LG, Kimpel MW, Liang T, McClintick JN, McCall K, Morse M, Edenberg
HJ. Identification of candidate genes for alcohol preference by expression
profiling of congenic rat strains. Alcohol Clin Exp Res. 2007;31:1089–98.
49. Liu J, Lewohl JM, Harris RA, Iyer VR, Dodd PR, Randall PK, Mayfield RD.
Patterns of gene expression in the frontal cortex discriminate alcoholic from
nonalcoholic individuals. Neuropsychopharmacology. 2006;31:1574–82.
50. Mayfield RD, Lewohl JM, Dodd PR, Herlihy A, Liu J, Harris RA. Patterns of
gene expression are altered in the frontal and motor cortices of human
alcoholics. J Neurochem. 2002;81:802–13.
51. Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA. Gene
expression in human alcoholism: microarray analysis of frontal cortex.
Alcohol Clin Exp Res. 2000;24:1873–82.
52. Mamdani M, Williamson V, McMichael GO, Blevins T, Aliev F, Adkins A, Hack L,
Bigdeli T, van der Vaart AD, Web BT, et al. Integrating mRNA and miRNA
weighted gene co-expression networks with eQTLs in the nucleus accumbens
of subjects with alcohol dependence. PLoS One. 2015;10:e0137671.
53. Chan KT, Roadcap DW, Holoweckyj N, Bear JE. Coronin 1C harbours a
second actin-binding site that confers co-operative binding to F-actin.
Biochem J. 2012;444:89–96.
54. Jansen EJ, Martens GJ. Novel insights into V-ATPase functioning: distinct
roles for its accessory subunits ATP6AP1/Ac45 and ATP6AP2/(pro) renin
receptor. Curr Protein Pept Sci. 2012;13:124–33.
55. Serezani CH, Aronoff DM, Sitrin RG, Peters-Golden M. FcgammaRI ligation
leads to a complex with BLT1 in lipid rafts that enhances rat lung
macrophage antimicrobial functions. Blood. 2009;114:3316–24.
56. Nakanishi H. Microglial functions and proteases. Mol Neurobiol. 2003;27:
163–76.
57. Montalbetti N, Simonin A, Kovacs G, Hediger MA. Mammalian iron
transporters: families SLC11 and SLC40. Mol Asp Med. 2013;34:270–87.
58. Mao Y, Finnemann SC. Essential diurnal Rac1 activation during retinal
phagocytosis requires alphavbeta5 integrin but not tyrosine kinases focal
adhesion kinase or Mer tyrosine kinase. Mol Biol Cell. 2012;23:1104–14.
59. Sun Y, Grabowski GA. Altered autophagy in the mice with a deficiency of
saposin A and saposin B. Autophagy. 2013;9:1115–6.
60. Alvey C, Discher DE. Engineering macrophages to eat cancer: from “marker of
self” CD47 and phagocytosis to differentiation. J Leukoc Biol. 2017;102:31–40.
61. Weiskopf K. Cancer immunotherapy targeting the CD47/SIRPalpha axis. Eur J
Cancer. 2017;76:100–9.
62. Daitoku S, Takenaka K, Yamauchi T, Yurino A, Jinnouchi F, Nunomura T, Eto
T, Kamimura T, Higuchi M, Harada N, et al. Calreticulin mutation does not
contribute to disease progression in essential thrombocythemia by
inhibiting phagocytosis. Exp Hematol. 2016;44:817–825.e813.
63. Voss OH, Tian L, Murakami Y, Coligan JE, Krzewski K. Emerging role of
CD300 receptors in regulating myeloid cell efferocytosis. Mol Cell Oncol.
2015;2:e964625.
64. Couturier J, Stancu IC, Schakman O, Pierrot N, Huaux F, Kienlen-Campard P,
Dewachter I, Octave JN. Activation of phagocytic activity in astrocytes by
reduced expression of the inflammasome component ASC and its
implication in a mouse model of Alzheimer disease. J Neuroinflammation.
2016;13:20.
65. Smathers RL, Chiang DJ, McMullen MR, Feldstein AE, Roychowdhury S, Nagy
LE. Soluble IgM links apoptosis to complement activation in early alcoholic
liver disease in mice. Mol Immunol. 2016;72:9–18.
66. Cohen JI, Roychowdhury S, McMullen MR, Stavitsky AB, Nagy LE.
Complement and alcoholic liver disease: role of C1q in the pathogenesis of
ethanol-induced liver injury in mice. Gastroenterology. 2010;139:664–74.
674.e661
67. Sebastian BM, Roychowdhury S, Tang H, Hillian AD, Feldstein AE, Stahl GL,
Takahashi K, Nagy LE. Identification of a cytochrome P4502E1/Bid/C1q-
dependent axis mediating inflammation in adipose tissue after chronic
ethanol feeding to mice. J Biol Chem. 2011;286:35989–97.
68. Bodea LG, Wang Y, Linnartz-Gerlach B, Kopatz J, Sinkkonen L, Musgrove R,
Kaoma T, Muller A, Vallar L, Di Monte DA, et al. Neurodegeneration by
activation of the microglial complement-phagosome pathway. J Neurosci.
2014;34:8546–56.
69. Conway Morris A, Kefala K, Wilkinson TS, Dhaliwal K, Farrell L, Walsh T,
Mackenzie SJ, Reid H, Davidson DJ, Haslett C, et al. C5a mediates peripheral
blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care
Med. 2009;180:19–28.
70. Morris MR, Doull IJ, Dewitt S, Hallett MB. Reduced iC3b-mediated
phagocytotic capacity of pulmonary neutrophils in cystic fibrosis. Clin Exp
Immunol. 2005;142:68–75.
71. Czirr E, Castello NA, Mosher KI, Castellano JM, Hinkson IV, Lucin KM, Baeza-
Raja B, Ryu JK, Li L, Farina SN, et al. Microglial complement receptor 3
regulates brain Abeta levels through secreted proteolytic activity. J Exp
Med. 2017;214:1081–92.
72. Fu H, Liu B, Frost JL, Hong S, Jin M, Ostaszewski B, Shankar GM, Costantino
IM, Carroll MC, Mayadas TN, Lemere CA. Complement component C3 and
complement receptor type 3 contribute to the phagocytosis and clearance
of fibrillar Abeta by microglia. Glia. 2012;60:993–1003.
73. Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry
KM, Shi Q, Rosenthal A, Barres BA, et al. Complement and microglia mediate
early synapse loss in Alzheimer mouse models. Science. 2016;352:712–6.
74. Choucair-Jaafar N, Laporte V, Levy R, Poindron P, Lombard Y, Gies JP.
Complement receptor 3 (CD11b/CD18) is implicated in the elimination of
beta-amyloid peptides. Fundam Clin Pharmacol. 2011;25:115–22.
75. Morland B, Morland J. Reduced Fc-receptor function in human monocytes
exposed to ethanol in vitro. Alcohol Alcohol. 1984;19:211–7.
76. Zuiable A, Wiener E, Wickramasinghe SN. In vitro effects of ethanol on the
phagocytic and microbial killing activities of normal human monocytes and
monocyte-derived macrophages. Clin Lab Haematol. 1992;14:137–47.
77. Saito M, Chakraborty G, Hui M, Masiello K, Saito M. Ethanol-induced
neurodegeneration and glial activation in the developing brain. Brain Sci.
2016;6:31.
78. Ahlers KE, Karacay B, Fuller L, Bonthius DJ, Dailey ME. Transient activation of
microglia following acute alcohol exposure in developing mouse neocortex
is primarily driven by BAX-dependent neurodegeneration. Glia. 2015;63:
1694–713.
79. Gofman L, Cenna JM, Potula R. P2X4 receptor regulates alcohol-induced
responses in microglia. J NeuroImmune Pharmacol. 2014;9:668–78.
80. Gaikwad S, Larionov S, Wang Y, Dannenberg H, Matozaki T, Monsonego A, Thal
DR, Neumann H. Signal regulatory protein-beta1: a microglial modulator of
phagocytosis in Alzheimer's disease. Am J Pathol. 2009;175:2528–39.
Kalinin et al. Journal of Neuroinflammation  (2018) 15:141 Page 10 of 11
81. Paradisi S, Matteucci A, Fabrizi C, Denti MA, Abeti R, Breit SN, Malchiodi-
Albedi F, Mazzanti M. Blockade of chloride intracellular ion channel 1
stimulates Abeta phagocytosis. J Neurosci Res. 2008;86:2488–98.
82. Kok EH, Karppinen TT, Luoto T, Alafuzoff I, Karhunen PJ. Beer drinking
associates with lower burden of amyloid beta aggregation in the brain:
Helsinki sudden death series. Alcohol Clin Exp Res. 2016;40:1473–8.
83. Weyerer S, Schaufele M, Wiese B, Maier W, Tebarth F, van den Bussche H,
Pentzek M, Bickel H, Luppa M, Riedel-Heller SG. Current alcohol
consumption and its relationship to incident dementia: results from a 3-year
follow-up study among primary care attenders aged 75 years and older.
Age Ageing. 2011;40:456–63.
84. Venkataraman A, Kalk N, Sewell G, Ritchie CW, Lingford-Hughes A. Alcohol
and Alzheimer’s disease-does alcohol dependence contribute to beta-
amyloid deposition, neuroinflammation and neurodegeneration in
Alzheimer’s disease? Alcohol Alcohol. 2017;52:151–8.
85. Piazza-Gardner AK, Gaffud TJ, Barry AE. The impact of alcohol on Alzheimer’s
disease: a systematic review. Aging Ment Health. 2013;17:133–46.
86. Munoz G, Urrutia JC, Burgos CF, Silva V, Aguilar F, Sama M, Yeh HH, Opazo
C, Aguayo LG. Low concentrations of ethanol protect against
synaptotoxicity induced by Abeta in hippocampal neurons. Neurobiol
Aging. 2015;36:845–56.
87. Ehrlich D, Pirchl M, Humpel C. Effects of long-term moderate ethanol and
cholesterol on cognition, cholinergic neurons, inflammation, and vascular
impairment in rats. Neuroscience. 2012;205:154–66.
Kalinin et al. Journal of Neuroinflammation  (2018) 15:141 Page 11 of 11
